Header Logo

Connection

GARABED EKNOYAN to Risk Assessment

Back to Details
This is a "connection" page, showing publications GARABED EKNOYAN has written about Risk Assessment.
GARABED EKNOYAN
Connection Strength
0.069
Risk Assessment
  1. Progress and promise in the management of chronic kidney disease. CMAJ. 2008 Nov 18; 179(11):1107-8.
    View in: PubMed
    Score: 0.038
  2. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011 Nov; 80(10):1080-91.
    View in: PubMed
    Score: 0.011
  3. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol Dial Transplant. 2012 Feb; 27(2):640-6.
    View in: PubMed
    Score: 0.011
  4. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.